Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.4 HKD | +4.24% | +15.05% | -2.69% |
10:44am | Hong Kong Stocks Surge on Upbeat China Outlook | MT |
09:22am | Nomura Adjusts Ping An Insurance’s Price Target to HK$54.41 From HK$54.12, Keeps at Buy | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Its low valuation, with P/E ratio at 6.17 and 5.7 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.69% | 90.05B | B | ||
-0.79% | 91.17B | B- | ||
+19.01% | 74.89B | D+ | ||
-25.86% | 69.66B | B+ | ||
+1.09% | 28.36B | B | ||
+18.86% | 28.14B | B | ||
+2.31% | 26.49B | A | ||
+1.92% | 17.67B | C+ | ||
-8.12% | 15.52B | B | ||
+21.76% | 12.76B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 601318 Stock
- 2318 Stock
- Ratings Ping An Insurance Group Company